Shanghai No1 Pharmacy Co Ltd (600833) - Net Assets
Based on the latest financial reports, Shanghai No1 Pharmacy Co Ltd (600833) has net assets worth CN¥1.17 Billion CNY (≈ $171.25 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥2.03 Billion ≈ $297.15 Million USD) and total liabilities (CN¥860.40 Million ≈ $125.90 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Shanghai No1 Pharmacy Co Ltd liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CN¥1.17 Billion |
| % of Total Assets | 57.63% |
| Annual Growth Rate | 6.23% |
| 5-Year Change | 52.73% |
| 10-Year Change | 46.14% |
| Growth Volatility | 75.1 |
Shanghai No1 Pharmacy Co Ltd - Net Assets Trend (1994–2024)
This chart illustrates how Shanghai No1 Pharmacy Co Ltd's net assets have evolved over time, based on quarterly financial data. Also explore total assets of Shanghai No1 Pharmacy Co Ltd for the complete picture of this company's asset base.
Annual Net Assets for Shanghai No1 Pharmacy Co Ltd (1994–2024)
The table below shows the annual net assets of Shanghai No1 Pharmacy Co Ltd from 1994 to 2024. For live valuation and market cap data, see Shanghai No1 Pharmacy Co Ltd stock valuation.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥1.14 Billion ≈ $167.46 Million |
+13.48% |
| 2023-12-31 | CN¥1.01 Billion ≈ $147.57 Million |
+5.19% |
| 2022-12-31 | CN¥958.68 Million ≈ $140.28 Million |
+23.24% |
| 2021-12-31 | CN¥777.92 Million ≈ $113.83 Million |
+3.82% |
| 2020-12-31 | CN¥749.32 Million ≈ $109.65 Million |
+2.32% |
| 2019-12-31 | CN¥732.34 Million ≈ $107.16 Million |
+9.37% |
| 2018-12-31 | CN¥669.57 Million ≈ $97.98 Million |
-6.23% |
| 2017-12-31 | CN¥714.07 Million ≈ $104.49 Million |
-2.98% |
| 2016-12-31 | CN¥736.00 Million ≈ $107.70 Million |
-6.01% |
| 2015-12-31 | CN¥783.09 Million ≈ $114.59 Million |
+20.30% |
| 2014-12-31 | CN¥650.97 Million ≈ $95.26 Million |
+21.42% |
| 2013-12-31 | CN¥536.14 Million ≈ $78.45 Million |
+7.26% |
| 2012-12-31 | CN¥499.84 Million ≈ $73.14 Million |
+16.40% |
| 2011-12-31 | CN¥429.41 Million ≈ $62.84 Million |
-1.48% |
| 2010-12-31 | CN¥435.88 Million ≈ $63.78 Million |
+8.36% |
| 2009-12-31 | CN¥402.25 Million ≈ $58.86 Million |
+28.04% |
| 2008-12-31 | CN¥314.16 Million ≈ $45.97 Million |
-20.17% |
| 2007-12-31 | CN¥393.54 Million ≈ $57.59 Million |
+60.13% |
| 2006-12-31 | CN¥245.77 Million ≈ $35.96 Million |
+5.63% |
| 2005-12-31 | CN¥232.68 Million ≈ $34.05 Million |
+14.83% |
| 2004-12-31 | CN¥202.62 Million ≈ $29.65 Million |
+6.93% |
| 2003-12-31 | CN¥189.49 Million ≈ $27.73 Million |
+7.48% |
| 2002-12-31 | CN¥176.31 Million ≈ $25.80 Million |
+6.52% |
| 2001-12-31 | CN¥165.52 Million ≈ $24.22 Million |
+141.35% |
| 2000-12-31 | CN¥-400.26 Million ≈ $-58.57 Million |
-43.83% |
| 1999-12-31 | CN¥-278.29 Million ≈ $-40.72 Million |
-378.36% |
| 1998-12-31 | CN¥99.97 Million ≈ $14.63 Million |
-71.05% |
| 1997-12-31 | CN¥345.33 Million ≈ $50.53 Million |
+13.10% |
| 1996-12-31 | CN¥305.33 Million ≈ $44.68 Million |
+6.17% |
| 1995-12-31 | CN¥287.59 Million ≈ $42.08 Million |
+54.00% |
| 1994-12-31 | CN¥186.74 Million ≈ $27.33 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Shanghai No1 Pharmacy Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 1848.2% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | CN¥582.27 Million | 51.27% |
| Common Stock | CN¥223.09 Million | 19.64% |
| Other Comprehensive Income | CN¥290.70 Million | 25.60% |
| Other Components | CN¥39.56 Million | 3.48% |
| Total Equity | CN¥1.14 Billion | 100.00% |
Shanghai No1 Pharmacy Co Ltd Competitors by Market Cap
The table below lists competitors of Shanghai No1 Pharmacy Co Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Shanghai Rychen Technologies Co. Ltd. A
SHE:301273
|
$406.44 Million |
|
Metrodata Electronics Tbk
JK:MTDL
|
$406.45 Million |
|
Jiangsu Wanlin Modern Logistic
SHG:603117
|
$406.84 Million |
|
XiAn Global Printing Co Ltd
SHE:002799
|
$406.97 Million |
|
Yibin Paper Industry Co Ltd
SHG:600793
|
$406.42 Million |
|
Shunya International Brand Consulting Beijing Co Ltd Class A
SHE:300612
|
$406.39 Million |
|
ADD Industry Zhejiang Co Ltd
SHG:603089
|
$406.39 Million |
|
JSL S.A
SA:JSLG3
|
$406.32 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Shanghai No1 Pharmacy Co Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 1,001,446,000 to 1,135,612,000, a change of 134,166,000 (13.4%).
- Net income of 163,061,274 contributed positively to equity growth.
- Dividend payments of 29,413,000 reduced retained earnings.
- Other comprehensive income increased equity by 122,479,238.
- Other factors decreased equity by 121,961,512.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CN¥163.06 Million | +14.36% |
| Dividends Paid | CN¥29.41 Million | -2.59% |
| Other Comprehensive Income | CN¥122.48 Million | +10.79% |
| Other Changes | CN¥-121.96 Million | -10.74% |
| Total Change | CN¥- | 13.40% |
Book Value vs Market Value Analysis
This analysis compares Shanghai No1 Pharmacy Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2.45x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 15.37x to 2.45x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1994-12-31 | CN¥0.81 | CN¥12.45 | x |
| 1995-12-31 | CN¥0.79 | CN¥12.45 | x |
| 1996-12-31 | CN¥0.87 | CN¥12.45 | x |
| 1997-12-31 | CN¥1.48 | CN¥12.45 | x |
| 1998-12-31 | CN¥-0.37 | CN¥12.45 | x |
| 1999-12-31 | CN¥-1.15 | CN¥12.45 | x |
| 2000-12-31 | CN¥-1.74 | CN¥12.45 | x |
| 2001-12-31 | CN¥0.72 | CN¥12.45 | x |
| 2002-12-31 | CN¥0.76 | CN¥12.45 | x |
| 2003-12-31 | CN¥0.82 | CN¥12.45 | x |
| 2004-12-31 | CN¥0.88 | CN¥12.45 | x |
| 2005-12-31 | CN¥1.01 | CN¥12.45 | x |
| 2006-12-31 | CN¥1.06 | CN¥12.45 | x |
| 2007-12-31 | CN¥1.82 | CN¥12.45 | x |
| 2008-12-31 | CN¥1.45 | CN¥12.45 | x |
| 2009-12-31 | CN¥1.80 | CN¥12.45 | x |
| 2010-12-31 | CN¥1.98 | CN¥12.45 | x |
| 2011-12-31 | CN¥1.84 | CN¥12.45 | x |
| 2012-12-31 | CN¥2.21 | CN¥12.45 | x |
| 2013-12-31 | CN¥2.32 | CN¥12.45 | x |
| 2014-12-31 | CN¥2.96 | CN¥12.45 | x |
| 2015-12-31 | CN¥3.39 | CN¥12.45 | x |
| 2016-12-31 | CN¥3.33 | CN¥12.45 | x |
| 2017-12-31 | CN¥3.09 | CN¥12.45 | x |
| 2018-12-31 | CN¥2.97 | CN¥12.45 | x |
| 2019-12-31 | CN¥3.28 | CN¥12.45 | x |
| 2020-12-31 | CN¥3.36 | CN¥12.45 | x |
| 2021-12-31 | CN¥3.43 | CN¥12.45 | x |
| 2022-12-31 | CN¥4.24 | CN¥12.45 | x |
| 2023-12-31 | CN¥4.49 | CN¥12.45 | x |
| 2024-12-31 | CN¥5.08 | CN¥12.45 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Shanghai No1 Pharmacy Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 14.36%
- The company shows good efficiency in utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 8.51%
- • Asset Turnover: 0.97x
- • Equity Multiplier: 1.74x
- Recent ROE (14.36%) is above the historical average (6.48%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1994 | 13.27% | 20.22% | 0.17x | 3.88x | CN¥6.11 Million |
| 1995 | 10.33% | 9.08% | 0.17x | 6.68x | CN¥606.20K |
| 1996 | 10.17% | 7.39% | 0.20x | 6.89x | CN¥347.50K |
| 1997 | -21.34% | -25.05% | 0.25x | 3.45x | CN¥-106.72 Million |
| 1998 | 0.00% | 0.00% | -0.05x | 0.00x | CN¥-265.55 Million |
| 1999 | 0.00% | 0.00% | -0.01x | 0.00x | CN¥-154.65 Million |
| 2000 | 0.00% | -3091.91% | 0.01x | 0.00x | CN¥-89.51 Million |
| 2001 | 13.46% | 8.46% | 0.55x | 2.92x | CN¥5.73 Million |
| 2002 | 7.20% | 2.66% | 1.00x | 2.71x | CN¥-4.94 Million |
| 2003 | 6.82% | 2.55% | 1.05x | 2.56x | CN¥-6.01 Million |
| 2004 | 6.49% | 2.41% | 1.27x | 2.12x | CN¥-7.10 Million |
| 2005 | 6.10% | 2.36% | 1.75x | 1.48x | CN¥-9.06 Million |
| 2006 | 5.30% | 2.15% | 1.25x | 1.96x | CN¥-11.52 Million |
| 2007 | 5.11% | 2.20% | 1.31x | 1.77x | CN¥-19.22 Million |
| 2008 | 6.38% | 2.08% | 1.64x | 1.88x | CN¥-11.34 Million |
| 2009 | 9.94% | 3.86% | 1.44x | 1.79x | CN¥-221.40K |
| 2010 | 7.07% | 2.64% | 1.46x | 1.84x | CN¥-12.56 Million |
| 2011 | 8.70% | 2.90% | 1.60x | 1.88x | CN¥-5.49 Million |
| 2012 | 7.39% | 2.68% | 1.52x | 1.81x | CN¥-12.85 Million |
| 2013 | 6.48% | 2.54% | 1.47x | 1.73x | CN¥-18.65 Million |
| 2014 | 5.75% | 2.62% | 1.31x | 1.68x | CN¥-27.37 Million |
| 2015 | 5.30% | 2.76% | 1.21x | 1.59x | CN¥-36.44 Million |
| 2016 | 6.31% | 3.03% | 1.28x | 1.63x | CN¥-26.86 Million |
| 2017 | 6.15% | 2.79% | 1.37x | 1.61x | CN¥-27.23 Million |
| 2018 | 7.12% | 4.01% | 1.09x | 1.63x | CN¥-19.07 Million |
| 2019 | 7.32% | 4.27% | 1.02x | 1.68x | CN¥-19.44 Million |
| 2020 | 9.23% | 4.32% | 1.14x | 1.88x | CN¥-5.69 Million |
| 2021 | 6.41% | 3.53% | 1.05x | 1.73x | CN¥-27.67 Million |
| 2022 | 15.08% | 5.41% | 1.30x | 2.14x | CN¥48.39 Million |
| 2023 | 8.91% | 4.91% | 0.98x | 1.86x | CN¥-10.87 Million |
| 2024 | 14.36% | 8.51% | 0.97x | 1.74x | CN¥49.50 Million |
Industry Comparison
This section compares Shanghai No1 Pharmacy Co Ltd's net assets metrics with peer companies in the Pharmaceutical Retailers industry.
Industry Context
- Industry: Pharmaceutical Retailers
- Average net assets among peers: $2,090,510,187
- Average return on equity (ROE) among peers: 11.44%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Shanghai No1 Pharmacy Co Ltd (600833) | CN¥1.17 Billion | 13.27% | 0.74x | $406.42 Million |
| Cachet Pharmaceutical Co Ltd (002462) | $1.13 Billion | 5.78% | 0.70x | $586.93 Million |
| Yunnan Hongxiang Yixintang (002727) | $1.05 Billion | 22.94% | 0.97x | $1.10 Billion |
| Luyan Pharma Co Ltd (002788) | $2.56 Billion | 11.95% | 2.90x | $797.07 Million |
| Ji Yao Holding Group Co Ltd (300108) | $1.66 Billion | 8.18% | 0.40x | $20.47 Million |
| ShuYu Civilian Pharmacy Corp. Ltd. (301017) | $2.27 Billion | 10.12% | 2.47x | $791.77 Million |
| Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd (301126) | $1.68 Billion | 4.07% | 0.78x | $361.59 Million |
| Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A (301408) | $947.01 Million | 16.98% | 1.72x | $1.32 Billion |
| Laobaixing Pharmacy (603883) | $7.17 Billion | 7.24% | 2.09x | $1.54 Billion |
| Yifeng Pharmacy (603939) | $356.28 Million | 15.68% | 1.37x | $4.06 Billion |
About Shanghai No1 Pharmacy Co Ltd
Shanghai No.1 Pharmacy Co.,Ltd., together with its subsidiaries, engages in the retail and wholesale of pharmaceutical products in China. It sells food, medical equipment, health convenience products, and other commodities. The company serves terminal medical institutions, pharmacies, commodity distribution companies, and company franchise stores companies. Shanghai No. 1 Pharmacy Co.,Ltd. was fo… Read more